When Tommy John stepped onto the mound in 1974, few could imagine that his elbow would become the most famous in baseball history. Dr. Frank Jobe, then a relatively unknown orthopedic surgeon, performed a procedure that would later bear John’s name, offering a lifeline to a sport where arm injuries had often meant the end of a career.
The operation, which replaced the damaged ulnar collateral ligament with a tendon from the patient’s own forearm, was the first successful ulnar collateral ligament reconstruction. Its success not only saved John’s own pitching future but also introduced a surgical standard that would later be adopted by more than four in ten major league pitchers.
A Turning Point in Pitching Medicine
John’s comeback was nothing short of remarkable. After a grueling rehabilitation, he returned to the majors in 1976 and logged over two hundred innings, surpassing his pre‑injury performance and proving that the surgery could restore — and even enhance — a pitcher’s durability.
The ripple effects of that breakthrough spread quickly. By the time the 2020s arrived, more than forty percent of MLB arms had undergone the intervention, with stars such as Justin Verlander, Shohei Ohtani and Chris Sale all crediting the procedure for extending their careers. The technique’s influence reached beyond baseball, reshaping approaches to elbow injuries in other sports.
Beyond the operating room, the story of John and Jobe is one of perseverance and humility. Jobe’s modest demeanor and John’s relentless determination earned Jobe a place in the Baseball Hall of Fame in 2013, while John’s name became synonymous with both hope and trepidation among pitchers facing elbow trouble.